Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$22.14 - $32.3 $7.09 Million - $10.4 Million
-320,454 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.36 - $34.11 $341,928 - $459,905
13,483 Added 4.39%
320,454 $8.87 Million
Q3 2021

Nov 03, 2021

SELL
$20.93 - $31.0 $6.34 Million - $9.38 Million
-302,714 Reduced 49.65%
306,971 $9.52 Million
Q2 2021

Aug 12, 2021

SELL
$18.43 - $21.78 $6,671 - $7,884
-362 Reduced 0.06%
609,685 $12.9 Million
Q1 2021

May 13, 2021

BUY
$16.19 - $21.22 $2.94 Million - $3.86 Million
181,791 Added 42.45%
610,047 $12.3 Million
Q4 2020

Feb 12, 2021

BUY
$9.92 - $16.43 $4.25 Million - $7.04 Million
428,256 New
428,256 $6.86 Million
Q1 2019

May 15, 2019

SELL
$12.17 - $20.92 $420,303 - $722,493
-34,536 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$17.75 - $27.2 $1,011 - $1,550
57 Added 0.17%
34,536 $688,000
Q3 2018

Nov 14, 2018

BUY
$20.1 - $28.75 $693,027 - $991,271
34,479 New
34,479 $0

Others Institutions Holding EVH

About Evolent Health, Inc.


  • Ticker EVH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 97,063,696
  • Market Cap $1.1B
  • Description
  • Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...
More about EVH
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.